Skip to main content
Clinical Trials/ISRCTN17573492
ISRCTN17573492Completed未知

A double-blind randomised placebo-controlled feasibility study to assess the impact of octreotide infusion during liver transplantation on post-operative renal failure.

niversity College London0 sites30 target enrollmentStarted: October 5, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Aged =18 years
  • 2. Undergoing primary liver transplantation of a whole or partial liver graft from a cardiac or brain dead donor
  • 3. Provision of written informed consent

Exclusion Criteria

  • 1. Previous solid organ transplant
  • 2. Acute liver failure
  • 3. Fulminant hepatic failure
  • 4. Patients receiving a living donor liver graft
  • 5. Patients currently admitted to ICU prior to transplantation
  • 6. Requirement of haemodialysis or Continuous Veno-Venous Hemofiltration (CVVHF) pre-operatively
  • 7. Known allergy or adverse reaction to octreotide
  • 8. Pre-operative decision to use intra-operative CVVHF
  • 9. A positive pregnancy test

Investigators

Sponsor
niversity College London

Similar Trials

A feasibility study of octreotide infusion... | Clinical Trial